BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31016892)

  • 1. An integrated analysis reveals the oncogenic function of lncRNA LINC00511 in human ovarian cancer.
    Wang J; Tian Y; Zheng H; Ding Y; Wang X
    Cancer Med; 2019 Jun; 8(6):3026-3035. PubMed ID: 31016892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis.
    Jiang B; Hailong S; Yuan J; Zhao H; Xia W; Zha Z; Bin W; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():500-507. PubMed ID: 30243082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic long noncoding RNA landscape in breast cancer.
    Xu S; Kong D; Chen Q; Ping Y; Pang D
    Mol Cancer; 2017 Jul; 16(1):129. PubMed ID: 28738804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma.
    Cui H; Zhang Y; Zhang Q; Chen W; Zhao H; Liang J
    Cancer Med; 2017 Dec; 6(12):2932-2941. PubMed ID: 29047230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
    Chen Y; Yu X; Xu Y; Shen H
    Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
    Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
    Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide analysis of long noncoding RNA profile identifies differentially expressed lncRNAs associated with Esophageal cancer.
    Liu W; Zhang Y; Chen M; Shi L; Xu L; Zou X
    Cancer Med; 2018 Aug; 7(8):4181-4189. PubMed ID: 29926523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer.
    Zhang J; Sui S; Wu H; Zhang J; Zhang X; Xu S; Pang D
    Cell Death Dis; 2019 Aug; 10(8):599. PubMed ID: 31395854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and Investigation of an LINC00284-Associated Regulatory Network in Serous Ovarian Carcinoma.
    Wang S; Zhang L; Tao L; Pang L; Fu R; Fu Y; Liang W; Ding Y; Jia W
    Dis Markers; 2020; 2020():9696285. PubMed ID: 32076467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification.
    Akrami R; Jacobsen A; Hoell J; Schultz N; Sander C; Larsson E
    PLoS One; 2013; 8(11):e80306. PubMed ID: 24265805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
    Fang L; Wang H; Li P
    Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of differential expressed lncRNAs in human thyroid cancer by a genome-wide analyses.
    Lu W; Xu Y; Xu J; Wang Z; Ye G
    Cancer Med; 2018 Aug; 7(8):3935-3944. PubMed ID: 29923329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
    Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
    Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of oncogenic long noncoding RNAs CASC9 and LINC00152 in oral carcinoma through genome-wide comprehensive analysis.
    Chen M; Xu X; Ma H
    Anticancer Drugs; 2019 Apr; 30(4):356-362. PubMed ID: 30543527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer.
    Lou Y; Jiang H; Cui Z; Wang X; Wang L; Han Y
    Int J Mol Med; 2018 Jul; 42(1):91-104. PubMed ID: 29577163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
    Chen Y; Bi F; An Y; Yang Q
    J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer.
    Lu YM; Wang Y; Liu SQ; Zhou MY; Guo YR
    Oncol Rep; 2018 Nov; 40(5):2964-2976. PubMed ID: 30132558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative profiling analysis identifies the oncogenic long noncoding RNA DUXAP8 in oral cancer.
    Chen M; Zheng Y; Xie J; Zhen E; Zhou X
    Anticancer Drugs; 2020 Sep; 31(8):792-798. PubMed ID: 32304409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.